Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$837K Sell
9,227
-1,350
-13% -$123K 0.25% 75
2026
Q1
$1.09M Sell
10,577
-3,232
-23% -$365K 0.37% 55
2025
Q4
$1.73M Buy
13,809
+30
+0.2% +$3.82K 0.56% 36
2025
Q3
$1.85M Buy
13,779
+404
+3% +$53K 0.62% 35
2025
Q2
$1.82M Sell
13,375
-467
-3% -$61.6K 0.67% 33
2025
Q1
$1.84M Sell
13,842
-25
-0.2% -$3.18K 0.72% 31
2024
Q4
$1.57M Buy
13,867
+5,782
+72% +$668K 0.6% 35
2024
Q3
$922K Sell
8,085
-178
-2% -$19.5K 0.4% 58
2024
Q2
$859K Sell
8,263
-953
-10% -$101K 0.4% 55
2024
Q1
$1.05M Buy
9,216
+471
+5% +$54K 0.51% 40
2023
Q4
$963K Buy
+8,745
New +$874K 0.59% 38

Other funds holding ABT

Canopy Partners's ABT Position: Q2 2026 in Review

Canopy Partners reduced its Abbott (ABT) stake by 13% in Q2 2026, selling an estimated $123K and leaving 9,227 shares worth $837K. The position accounts for 0.25% of the portfolio, ranked #75.

Canopy Partners first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.85M in Q3 2025. 886 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Canopy Partners held 9,227 shares of Abbott worth $837K as of Q2 2026.
  • Canopy Partners sold 1,350 Abbott shares in Q2 2026, an estimated $123K.
  • Abbott made up 0.25% of Canopy Partners's portfolio in Q2 2026, its #75 holding.
  • Canopy Partners first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Canopy Partners's Abbott position peaked at $1.85M in Q3 2025.
  • 886 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.